T1	Participants 79 152	acute moderate to severe asthma in children between 5 and 15 years of age
T2	Participants 489 677	Children aged 5-15 years (without prior use of montelukast) with acute moderate to severe asthma exacerbation, as defined using Modified Pulmonary Index Score (MPIS) > or =9, were enrolled
T3	Participants 1069 1158	117 children (60 in montelukast group and 57 in placebo group) were enrolled in the study
